3,668 results on '"Rosenberg, Steven"'
Search Results
102. HYPOTHESIS TESTING FOR NETWORK DATA IN FUNCTIONAL NEUROIMAGING
103. Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer
104. Using adaptive behavior scores to convey level of functioning in children with autism spectrum disorder: Evidence from the Study to Explore Early Development
105. Cancer Regression and Autoimmunity Induced by Cytotoxic T Lymphocyte-Associated Antigen 4 Blockade in Patients with Metastatic Melanoma
106. Some Aspects of Calcium Chemistry in the Bayer Process
107. Layered Double Hydroxides in the Bayer Process: Past, Present and Future
108. Mathai-Quillen forms and Lefschetz theory
109. Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study
110. Cancer Regression and Autoimmunity in Patients after Clonal Repopulation with Antitumor Lymphocytes
111. Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma
112. Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanoma
113. Nonlocal invariants in index theory
114. Bounded and $L^2$ Harmonic Forms on Universal Covers
115. CD4 + T Cell Recognition of MHC Class II-Restricted Epitopes from NY-ESO-1 Presented by a Prevalent HLA DP4 Allele: Association with NY-ESO-1 Antibody Production
116. Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients
117. Risk factors and clinical correlates of sensory dysfunction in preschool children with and without autism spectrum disorder.
118. Brief Report: Prevalence of Self-Injurious Behaviors among Children with Autism Spectrum Disorder--A Population-Based Study
119. Homotopy and Homology Vanishing Theorems and the Stability of Stochastic Flows
120. Cloning Genes Encoding MHC Class II-Restricted Antigens: Mutated CDC27 as a Tumor Antigen
121. Vaccination with a Recombinant Vaccinia Virus Encoding a "self" Antigen Induces Autoimmune Vitiligo and Tumor Cell Destruction in Mice: Requirement for Cd4 + T Lymphocytes
122. Traces and Characteristic Classes in Infinite Dimensions
123. Receptor-Independent Role of Urokinase-Type Plasminogen Activator in Pericellular Plasmin and Matrix Metalloproteinase Proteolysis during Vascular Wound Healing in Mice
124. Phenotypic signatures of circulating neoantigen-reactive CD8+ T cells in patients with metastatic cancers
125. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer
126. Cell surface marker-based capture of neoantigen-reactive CD8+T-cell receptors from metastatic tumor digests
127. Supplementary Figures from Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer
128. Supplementary Table 4 from Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer
129. Supplementary Data from Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors
130. Supplementary Figure from Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors
131. Supplementary Table S2 from Single-Cell Transcriptome Analysis Reveals Gene Signatures Associated with T-cell Persistence Following Adoptive Cell Therapy
132. Data from Single-Cell Transcriptome Analysis Reveals Gene Signatures Associated with T-cell Persistence Following Adoptive Cell Therapy
133. Supplementary Figure 5 from Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer
134. Supplementary Table 3 from Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer
135. Supplementary Tables 1 and 2 from Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer
136. Supplementary Figures and Tables 3, 5 and 6 from Single-Cell Transcriptome Analysis Reveals Gene Signatures Associated with T-cell Persistence Following Adoptive Cell Therapy
137. Data from Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors
138. Data from Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer
139. Supplementary Data from Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers
140. Data from Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers
141. Supplementary Movies 7-9 from Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma
142. Supplementary Figures from Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers
143. Supplementary Movies 4-6 from Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma
144. Data from Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma
145. Supplementary Table 1 from Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens
146. Supplementary figures 1 through 15 and Supplementary Tables 1 through 5 from Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor
147. Supplementary Movies 1-3 from Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma
148. Supplementary Figure 1 from Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens
149. Supplementary methods from Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma
150. Data from Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.